FDA issued a Warning Letter to Lowlite Investments, Inc. D/B/A Olympia Pharmacy on 2/18/2014 for a previous inspection.
483 OPS International D/B/A Olympia Pharmacy Apr 2018

483 OPS International D/B/A Olympia Pharmacy Apr 2018

Camerson Moore FDA$119.00 - Available Now

FDA investigators audited the OPS International D/B/A Olympia Pharmacy - Orlando, FL, United States facility and issued inspectional observations (via FDA 483) on 13 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Apr 2018
  • Location: Orlando, United States
  • FEI: 3009724085
Add To Cart